Latest / MBA Training Data / GDPR versus GxP audit trails: the deletion trap
Transcript
- 0:00Host: Welcome to the Leaders Insights podcast.
- 0:07Host: Today's episode, GXP Integrity, 21 CFR Part 11, and GDPR.
- 0:12Host: What happens when three regulatory regimes collide?
- 0:15Host: Here's a scenario that keeps farm executives awake.
- 0:18Host: You build a system to honor a patient's right to be forgotten.
- 0:21Host: And in doing so, you delete a record you were legally required to keep for 15 years.
- 0:26Host: Explain how a company does that to itself.
- 0:29Expert: What happens when three rules are pointing at the same piece of data, and each one thinks
- 0:36Expert: it's in charge.
- 0:37Expert: You've got GXP, that's Good Practice Quality Regulation, the rules governing how drugs
- 0:43Expert: get made and tested.
- 0:45Expert: You've got 21 CFR Part 11, the American Electronic Records Rule from the FDA.
- 0:51Expert: And you've got GDPR, Europe's Privacy Law.
- 0:55Expert: Which was written by different people in different decades, solving different problems.
- 1:00Host: Start with the first one.
- 1:01Host: What does GXP actually demand?
- 1:03Expert: GXP cares about one thing above all, the audit trail.
- 1:08Expert: That's the unbroken record of who did what to the data and when.
- 1:11Expert: If a lab technician changes a test result from fail to pass, GXP says, you must keep
- 1:17Expert: both values, the timestamp, the person, and the reason forever more or less.
- 1:23Expert: The record is sacred.
- 1:24Expert: You never delete, you only add.
- 1:27Host: And Part 11?
- 1:28Expert: Part 11 is the FDA saying, fine, you can use computers instead of paper, but prove the
- 1:33Expert: computer didn't lie.
- 1:35Expert: It demands electronic signatures tied to real humans, and it demands that audit trail be
- 1:40Expert: tamper-proof.
- 1:42Expert: So now the audit trail isn't just a nice habit, it's a federal requirement with inspectors
- 1:47Expert: who show up.
- 1:48Host: So far these two agree.
- 1:50Host: Keep everything, prove everything.
- 1:52Expert: Exactly.
- 1:53Expert: They're siblings.
- 1:54Expert: Then GDPR walks in and it has the opposite theology.
- 1:57Expert: GDPR says data about a person belongs to that person, and the person can demand you erase
- 2:03Expert: it.
- 2:04Expert: That's the right to be forgotten.
- 2:06Expert: It also says you should collect the minimum you need and delete it when you're done.
- 2:11Host: Two laws whispering, keep it forever.
- 2:14Host: One law shouting, delete it on request.
- 2:17Host: And the collision is exactly where the patient's data lives.
- 2:20Expert: In clinical trials, yes.
- 2:22Expert: A trial record contains a human being and gives their genome, their blood work, their
- 2:26Expert: side effects.
- 2:28Expert: GDPR sees a person with rights.
- 2:30Expert: GXP sees an immutable scientific record you'll defend to the FDA in 2040.
- 2:36Expert: Same row in the same database.
- 2:37Expert: That's the trap.
- 2:39Host: So when someone builds a consent system to satisfy GDPR, what breaks?
- 2:44Expert: They build what looks like a clean deletion function.
- 2:47Expert: Patient withdraws system purges.
- 2:49Expert: If the purge script doesn't understand the audit trail is holy, it reaches into the trail
- 2:54Expert: to scrub personal identifiers.
- 2:56Expert: And congratulations, you've now modified a Part 11 record.
- 3:00Expert: To an FDA inspector, a modified audit trail looks exactly like fraud.
- 3:05Expert: You didn't commit fraud, you just built a shredder and pointed it at your own alibi.
- 3:10Host: That's grim.
- 3:11Host: So how do the good ones resolve it?
- 3:13Expert: Pseudonymization, replacing the name with a code and keeping the key that links them
- 3:17Expert: somewhere separate and locked down.
- 3:20Expert: GDPR is largely satisfied because you can break the link on request without touching
- 3:24Expert: the science.
- 3:26Expert: The trial data stays intact.
- 3:28Expert: The audit trail stays whole.
- 3:30Expert: There's also a legal exemption.
- 3:32Expert: GDPR carves out research.
- 3:34Expert: So forget me isn't absolute when a drug's safety profile depends on that record.
- 3:40Expert: But you have to design for it upfront, not discover it during an inspection.
- 3:44Host: How many companies actually design for it upfront versus discovering it the hard way?
- 3:49Expert: Fewer than they'd admit.
- 3:50Expert: DB, TLabs, and I'll flag they sell data tooling, so read them with a squint.
- 3:56Expert: Put out numbers suggesting most regulated firms still can't trace a single field
- 4:00Expert: back through its full lineage.
- 4:02Expert: Cross-check that against MIT Sloan Management Review, which has been blunter.
- 4:07Expert: The governance gap isn't tooling, it's that nobody owns the conflict.
- 4:12Expert: Three regimes and often three different departments, none of whom talk before something
- 4:17Expert: breaks.
- 4:18Host: So who should own it?
- 4:19Expert: One person with authority over quality, privacy, and records at once.
- 4:24Expert: Usually the chief data officer because they're the only one who sees all three regimes
- 4:28Expert: on one screen.
- 4:29Host: Give me the one thing an exec does Monday morning.
- 4:32Expert: Take your GDPR deletion workflow and trace exactly what it touches.
- 4:37Expert: If it can reach your audit trail, stop it today.
- 4:40Expert: Delete the link, never the record.
- 4:42Host: Sources for today's episode.
- 4:44Host: The new stack, K nuggets, O'Reilly radar, towards data science, MIT Sloan Management Review,
- 4:51Host: DBT labs, vendor, data tooling.
- 4:54Host: That's a wrap.
- 4:55Host: Fresh CDO briefings drop daily at MBA-training.com.